Quantitative Investment Management, LLC Novavax Inc Transaction History

Quantitative Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $199,502 - $1.08 Million	51,286 New	51,286 $649,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $73,532 - $159,319	-12,766 Reduced 41.83%	17,753 $123,000
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $465,619 - $1.32 Million	-52,553 Reduced 63.26%	30,519 $313,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $473,655 - $1.98 Million	26,025 Added 45.62%	83,072 $1.51 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $903,408 - $1.87 Million	24,901 Added 77.46%	57,047 $2.93 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $2.24 Million - $4.59 Million	32,146 New	32,146 $2.37 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.